Frontier Medicines, a cutting-edge precision medicine company based in South San Francisco, CA, and Boston, MA, has successfully secured $80 million in funding to further its mission of developing innovative therapies targeting previously undruggable disease-causing proteins. Known for its revolutionary discovery and development platform, Frontier Medicines harnesses the power of chemoproteomics, covalent drug discovery, and machine learning to create a robust pipeline of groundbreaking medicines aimed at addressing critical healthcare challenges, particularly in oncology. This latest funding round will bolster Frontier's efforts to advance its lead program, which uniquely targets both the activated and inactive forms of KRAS G12C, a validated driver of several cancers that has posed significant treatment challenges until now. The company’s commitment to utilizing advanced scientific approaches embodies its vision of boldly advancing treatments to defeat disease, starting with cancer. With the support of this substantial capital infusion, Frontier Medicines is well-positioned to accelerate its research, expand its pipeline, and bring much-needed therapies to patients suffering from malignancies driven by KRAS mutations. As the healthcare landscape navigates the complexities of cancer treatment, Frontier Medicines stands at the forefront of innovation, dedicated to transforming the future of medicine and improving outcomes for patients with some of the most challenging conditions.

Frontier Medicines Secures $80 Million Funding in Series C Round for Revolutionary Precision Medicine Technology
Get the full Frontier Medicines company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Telepatia AI
Telepatia AI is a healthtech company on a mission to transform healthcare in Latin America and beyond. Born at Stanford and built by doctors for doctors, our platform introduces AI Healthcare Employees that work invisibly inside clinical workflows — transcribing consultations in real time, generating structured medical records, offering evidence-based decision support, and integrating seamlessly with any current health system — all without disrupting the physician’s flow. Already adopted by thousands of doctors and leading hospitals across the region, Telepatia has demonstrated measurable impact: reducing cognitive load, improving patient experience, and increasing adherence to clinical protocols. Our vision is bold: to turn scarcity into abundance by empowering healthcare professionals with scalable, trustworthy intelligence — and to pursue nothing less than the first Nobel Prize in Medicine for Latin America since 1984 with an AI Doctor.
$42.0M Series a
today

OneSoil
OneSoil transforms agricultural decisions from guesswork to data-driven precision. We help farmers and enterprises maximize profitability and sustainability through satellite intelligence and field-level insights. For Farmers & Agronomists: Our easy-to-use platform puts actionable data in your pocket. Scout fields efficiently with our mobile app, identify problem spots in real-time, and optimize input applications down to the hectare. For Enterprises: We deliver global agricultural intelligence at scale. Covering 59 countries with crop detection, yield forecasting, and supply chain monitoring - our data arrives 8 months ahead of official statistics, giving you the competitive edge that matters in commodity markets and strategic planning. The Same Technology, Two Markets Whether you're protecting your farm's bottom line or making billion-dollar decisions across global supply chains, OneSoil's satellite-derived insights, proprietary algorithms, and machine learning deliver precision agriculture that actually pays off. Quick to implement. Proven results. Built for real-world farming.
$1.2M Seed
today

Edvisor
Edvisor is the #1 Student Recruitment Software that helps international education companies streamline the way they sell education - whether they recruit students directly, through agencies or both. Supported by the biggest network of agencies, institutions and service providers, with more than 10K registered users across 42 countries and exclusive partnerships with the best associations and industry organizations.
$1.3M Pre-seed
today

Spoon Cereals
We find mornings just as hard as the next person, which is why we set out to make breakfast better for everyone...Better tasting, better for you and better for the planet. Our granolas are made with quality, good-for-you ingredients and baked in small batches, which means fresher granola and less waste.
$1.9M Seed
today

HyperLight
The information age relies on billions of devices converting signals between electricity and light waves. These integrated light circuits are the backbone of telecommunication infrastructures, data centers, sensors, and even secure quantum communications. Our devices set new benchmarks for performance, including extraordinary speed and efficiency, that will force industries to rethink and reimagine their current standards.
$80.0M Series c
today
Other recent Series c rounds
Companies that recently closed a Series c round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() HyperLight United States | Series c | $80.0M | today |
| 2 | ![]() Gradial United States | Series c | $65.0M | today |
| 3 | ![]() Embroker United States | Series c | $100.0M | 1d ago |
| 4 | ![]() Havenly Brands (Havenly, Interior Define, Burrow, The Citizenry, The Inside, and St. Frank) United States | Series c | $28.0M | 1d ago |
| 5 | ![]() Lilac Infotech India | Series c | $145.0M | 1d ago |


.png&w=3840&q=75)
